FDA alerts that widely used skin treatment may lead to severe complications
The FDA’s Warning on RF Microneedling The FDA has raised concerns about a popular skin treatment known for its celebrity following. While it’s been marketed to tackle issues like wrinkles, pigmentation, and acne scars, there have been some alarming reports regarding its safety. Radiofrequency (RF) microneedling involves using tiny electrodes to resurface the skin, reminiscent […]
FDA eases regulations on biosimilars to save billions on medications
Rising Costs in Prescription Drugs and the Role of Biosimilars The most rapidly growing area of health care spending is on prescription medications. At the forefront are biologics, which can cost up to $200,000 annually. There are “generic” alternatives known as biosimilars that have the potential to save Americans billions, yet their adoption is stymied […]
FDA takes action against fluoride supplements for kids
FDA Issues Warnings on Fluoride Medications for Children The Food and Drug Administration (FDA) has issued warnings to four companies concerning their sale of “unapproved fluoride-containing oral medications” intended for children under three, as well as for those at low or moderate risk of tooth decay. “This Halloween, the FDA is putting an end to […]
Senators Hawley and Cassidy raise concerns about FDA collaborations regarding medication for abortion.
Republican Senators Question FDA on Abortion Pill Safety On Wednesday, several Republican senators criticized the Food and Drug Administration (FDA) for allegedly broadening access to abortion pills without adequate oversight. They urged the agency to reinforce safety regulations and reassess its partnerships concerning these medications. During a conference call, Senators Josh Hawley from Missouri and […]
FDA Urges More Affordable Generic Versions of Expensive Drugs
New Push for Affordable Health Care Drugs President Trump’s health advisors announced an initiative to reduce health care costs by increasing the availability of innovative generic drugs during a press conference on Wednesday. The Food and Drug Administration (FDA) revealed plans to clear bureaucratic obstacles that currently protect its monopoly on biologics, many of which […]
Tylenol challenges autism allegations, criticizes suggested FDA warning label as lacking scientific support
Kenvue, the company behind Tylenol, is opposing proposed changes to its product labels, calling them “inappropriate.” This response comes after the Informed Consent Action Network urged the FDA to modify Tylenol’s labeling to warn pregnant women and their caregivers about potential risks linked to autism. This push was sparked by comments from the Trump administration […]
FDA should promptly halt approval of abortion medication
During President Trump’s first term, the FDA gave the green light to GenBioPro, marking the debut of the first generic mifepristone. Fast forward six years, the FDA has approved a second generic through Evita Solutions. It’s clear that the pro-life movement is keeping a close watch—not a mistake to think otherwise. The recent approval of […]
Egg recall due to salmonella concerns grows, according to the FDA
Recall of Eggs Due to Possible Salmonella Contamination Black Sheep Egg Company has announced a recall of several cartons of large, Grade A, free-range brown eggs potentially contaminated with salmonella, according to federal health officials. This action follows testing conducted by the Food and Drug Administration (FDA), which found salmonella in 40 environmental samples from […]
FDA Remained Quiet While Internal Reports on Possible Tylenol Hazards Accumulated
For almost ten years, the Food and Drug Administration (FDA) has overlooked its own experts’ recommendations regarding Tylenol safety for pregnant women, according to an internal report and presentation disclosed recently. The FDA’s general scientists have consistently urged that the potential risks of Tylenol during pregnancy be clearly communicated. They presented their findings in scientific […]
Decisions on abortion at the FDA should be based on science, not politics.
Recent developments in government health policy have taken many by surprise. President Trump’s unfounded assertions about Tylenol and its supposed link to autism, as well as the push for quick FDA approval of leucovorin, have highlighted a troubling disregard for scientific evidence in autism treatments. Additionally, Health and Human Services Secretary Robert F. Kennedy Jr.’s […]